Axsome Therapeutics
AXSM
AXSM
243 hedge funds and large institutions have $3.12B invested in Axsome Therapeutics in 2023 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 69 increasing their positions, 88 reducing their positions, and 24 closing their positions.
Holders
243
Holders Change
+18
Holders Change %
+8%
% of All Funds
3.56%
Holding in Top 10
13
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+30%
% of All Funds
0.19%
New
44
Increased
69
Reduced
88
Closed
24
Calls
$79.2M
Puts
$41.4M
Net Calls
+$37.8M
Net Calls Change
+$18.3M
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$98.6M |
| 2 |
PA
2
Perceptive Advisors
New York
|
$82.6M |
| 3 |
3
Millennium Management
New York
|
$72.4M |
| 4 |
4
Point72 Asset Management
Stamford,
Connecticut
|
$66.6M |
| 5 |
5
BlackRock
New York
|
$258M |
